Abstract
Solitary fibrous tumor (SFT) is rarely located in the central nervous system, and sella turcica involvement was reported in only two patients. We report the case of a 28-year-old man with a SFT of the sella turcica mimicking a pituitary nonfunctioning macroadenoma. He presented with optic nerve compression caused by a heterogeneous tumor located in the sellar and suprasellar area. At surgery, the tumor was hard and infiltrated the sellar diaphragm, so that resection resulted in a cerebrospinal fluid fistula. His postoperative course was also complicated by complete central diabetes insipidus, hypopituitarism, and two episodes of meningitis. After surgical resection, the diagnosis of SFT was reached on the basis of histological and immunohistochemical studies. He was discharged after 49 days. Ten months after surgery, he was clinically well, and magnetic resonance images showed no evidence of residual or recurrent tumor. SFT should be considered in the differential diagnosis of sellar and parasellar tumors.
Avoid common mistakes on your manuscript.
Introduction
Solitary fibrous tumors (SFT) are spindle-cell neoplasms that histologically and immunohistochemically resemble pleural-based SFTs, and are characterized immunohistochemically by CD34, vimentin, and bcl-2 reactivity [1–4]. They are rare in the central nervous system (CNS). A MEDLINE search in July 2008 for “solitary fibrous tumor” and “central nervous system” identified 30 articles describing 65 patients with non-spinal SFT of the CNS [1–31]. Involvement of the pituitary fossa was described only in two other patients [13, 22]. A SFT in the parasellar region was also described [18]. We report a case of SFT of the pituitary fossa and suprasellar area that presented with compression of the optic chiasm, mimicking a nonfunctioning pituitary macroadenoma.
Case Report
History and Examination
A 28-year-old white man presented with visual disturbance of 2 weeks duration. Clinical examination disclosed a well-developed man with no other medical complaints, except for nocturia once or twice a night in the last few years. His weight and height were, respectively, 84 kg and 1.80 m. Fasting serum aspartate aminotransferase, alanine aminotransferase, creatinine, urea nitrogen, glucose, alkaline phosphatase, calcium, and phosphorus levels, as well as blood hemoglobin and hematocrit, were normal. The total 24-h urine output volume varied from 2.5 to 3.5 L on three different days. Urine had a density of 1,007. Results of serum hormone levels are shown in Table 1.
Visual fields were evaluated by perimetry, disclosing right temporal hemianopsia and left inferior temporal quadrantanopsia. Radiological studies showed a heterogeneous mass inside and above the pituitary fossa with involvement of the optic chiasm; there was no calcification (Figs. 1, 2, 3, 4, and 5). The patient was diagnosed with a nonfunctioning pituitary macroadenoma.
Operation
Endoscopic transnasal transsphenoidal microsurgery was performed, and a hard, fibrous tumor was removed. The sellar diaphragm was involved by the lesion, and resection resulted in a cerebrospinal fluid (CSF) fistula. The sphenoid sinus was packed with fat and biological glue, and a lumbar drainage via percutaneous catheter was performed.
Histopathological Findings
The specimen contained a small amount of adenohypophysial parenchyma and a highly cellular spindle-cell proliferation with a dense, hyalinized collagenous stroma and dilated vascular spaces, some showing a staghorn-like appearance. Areas of cellular pleomorphism and increased cellularity were present, but mitoses were not identified (Fig. 6A). Immunohistochemistry showed strong immunoreactivity for vimentin (Fig. 6B), CD34 (Fig. 6C), and BcL-2; vessel walls stained for factor VIII. No specific staining for GFAP or S100 protein was found, and the tumor was negative for keratins, EMA, smooth muscle actin, and muscle-specific actin as well as myoD1, melanoma cocktail, and CD99. Cyclin D1 was localized in only a few scattered nuclei (less than 5% in the most positive area) and MIB-1 labeling had a similar pattern with an index of <5%. Stains for p53 were weakly positive in the majority of tumor nuclei. The features were considered to be those of SFT.
Postoperative Course
He developed hypopituitarism, as shown in Table 1, and complete central diabetes insipidus. Glucocorticoids, DDAVP, levothyroxine, and testosterone were administered. His postoperative course was also complicated by two episodes of meningitis, and he was discharged 49 days after the surgery. Two months after the surgery, his eyesight had improved markedly, and the total 24-h urine output volume varied from 1.5 to 2.0 L, while he was treated with intranasal DDAVP. The patient was clinically well, and MRI of the brain performed 10 months after the surgery showed no evidence of tumor.
Discussion
Pituitary adenomas comprise approximately 90% of sellar masses [32]. In a large series of 911 patients who underwent transsphenoidal surgery for sellar masses, 83 had lesions other than pituitary adenoma, including cysts, other primary tumors such as craniopharyngioma, chordoma, meningioma, or lymphoma, metastatic carcinoma, inflammatory lesions such as granulomas, infection or lymphocytic hypophysitis, and mucocele or aneurysm [32]. SFT is not usually included in this differential diagnosis.
Pituitary adenomas can manifest excess hormone production, visual disturbances, or hypopituitarism. Anterior pituitary failure, visual loss, and visual field abnormalities do not distinguish pituitary adenoma from a non-adenomatous lesion [32, 33]. In contrast, certain clinical findings, such as diabetes insipidus and cranial nerve palsies, are more commonly associated with non-adenomatous sellar masses. At presentation, our patient had mild polyuria and nocturia that he attributed to a habit of drinking tea at night. After surgery, total 24-h urine volume decreased and his nocturia resolved, while treated with DDAVP. It is possible that he had mild partial central diabetes insipidus before the surgery, but unfortunately, he was not tested to prove that hypothesis.
The initial diagnostic impression was of a nonfunctioning pituitary macroadenoma. The tumor was heterogeneous in T1-weighted images (T1WI), and T2-weighted images (T2WI), and after gadolinium, and in contrast-enhanced computed tomography, as shown in Figs. 1–4. The heterogeneity could have been due to cystic degeneration and hemorrhage that are not uncommon in larger pituitary adenomas [34]. However, histopathology confirmed this lesion to be a SFT.
Two SFTs involving the pituitary fossa have been previously described. In 2003, Cassarino et al. described a patient with an aggressive tumor invading the sphenoid sinus, cavernous sinus, and pituitary fossa, extending into the nasopharynx; this lesion was only partially resectable because of extensive bony invasion and encasement of the carotid artery [22]. Their first impression was of a malignant tumor originating in the pituitary fossa. In 2005, Pakasa et al. reported a patient with visual field loss in the left eye and a lesion in the pituitary fossa that was radiologically consistent with a pituitary adenoma with suprasellar extension. The tumor resection was incomplete, and it recurred twice in the same location within 3 years [13]. Both of these were shown to be SFT.
The origin of these lesions is not known, SFT in the CNS, although rare, are usually well-defined, solid, dura-based masses, occurring in much at the same sites as do meningioma [3, 20]. We speculate that SFT of the sella could have had its origin in the dural-based fibroblast or dendritic cells of the sellar diaphragm or in the mesenchyma of the vasculature of the pituitary stalk [3]. In this regard, they join a group of rare mesenchymal lesions of the pituitary including glomangioma [35] and other stromal tumors [36] that can mimic pituitary adenoma.
Unlike the other two reported cases, our patient has had a benign course, in accordance with the histopathological grade of the tumor. There was no evidence of invasion except for the sellar diaphragm that could be the site of origin of the tumor. Surgical resection was complete, and there was no evidence of tumor residua or recurrence in 10 months of follow-up surveillance.
We conclude that SFT can mimic pituitary adenoma and should be considered in the differential diagnosis of sellar and suprasellar masses.
References
Caroli E, Salvati M, Orlando ER, Lenzi J, Santoro A, Giangaspero F. Solitary fibrous tumors of the meninges: report of four cases and literature review. Neurosurg Rev 27(4):246–51, 2004.
Carneiro SS, Scheithauer BW, Nascimento AG, Hirose T, Davis DH. Solitary fibrous tumor of the meninges: a lesion distinct from fibrous meningioma. A clinicopathologic and immunohistochemical study. Am J Clin Pathol 106(2):217–24, 1996.
Metellus P, Bouvier C, Guyotat J, Fuentes S, Jouvet A, Vasiljevic A, et al. Solitary fibrous tumors of the central nervous system: clinicopathological and therapeutic considerations of 18 cases. Neurosurgery 60(4):715–22, 2007. doi:10.1227/01.NEU.0000255418.93678.AD; discussion 22.
Cummings T, Burchette J, McLendon R. CD34 and dural fibroblasts: the relationship to solitary fibrous tumor and meningioma. Acta Neuropathol 102(4):349–54, 2001.
Secer HI, Gonul E, Onguru O, Izci Y. Solitary fibrous tumour extending both supratentorially and infratentorially. J Clin Neurosci 15(7):830–3, 2008. doi:10.1016/j.jocn.2006.11.023.
Kinfe TM, Tschan CA, Stan AC, Krauss JK. Solitary fibrous tumor of the foramen of Monro. Clin Neurol Neurosurg 110(4):404–7, 2008. doi:10.1016/j.clineuro.2007.12.015.
Teranishi K, Yamamoto T, Nakao Y, Osada H, Wada R, Mori K. Recurrent solitary fibrous tumor of the falx cerebri with intraventricular extension: case report. Neurol Med Chir (Tokyo) 47(6):269–72, 2007. doi:10.2176/nmc.47.269.
Waldron JS, Tihan T, Parsa AT. Solitary fibrous tumor arising from cranial nerve VI in the prepontine cistern: case report and review of a tumor subpopulation mimicking schwannoma. Neurosurgery 59(4):E939–40, 2006. doi:10.1227/01.NEU.0000232660.21537.60; discussion E40.
Nakahara K, Yamada M, Shimizu S, Fujii K. Stereotactic radiosurgery as adjuvant treatment for residual solitary fibrous tumor. Case report. J Neurosurg 105(5):775–6, 2006. doi:10.3171/jns.2006.105.5.775.
Clarençon F, Bonneville F, Sichez J, Khalil I, Poirier J, Chiras J. Atypical location of a solitary fibrous tumor in the fourth ventricle. J Neuroradiol 33(4):279–80, 2006. doi:10.1016/S0150-9861(06)77281-9.
Scheie D, Reinholt F, Slettebø H, Skullerud K. Ribosome–lamella complex in aggressive solitary fibrous tumour of the meninges. Acta Neuropathol 110(3):312–4, 2005. doi:10.1007/s00401-005-1045-1.
Ritz R, Roser F, Bornemann A, Merkle M, Freudenstein D. Recurrence and increased proliferation rate of a solitary fibrous tumor in the central nervous system—case report and review of the literature. Clin Neuropathol 24(6):252–6, 2005.
Pakasa NM, Pasquier B, Chambonniere ML, Morrison AL, Khaddage A, Perret AG, et al. Atypical presentations of solitary fibrous tumors of the central nervous system: an analysis of unusual clinicopathological and outcome patterns in three new cases with a review of the literature. Virchows Arch 447(1):81–6, 2005. doi:10.1007/s00428-005-1220-8.
Hu SW, Tsai KB, Yang SF, Lee KS, Chai CY. Unusual solitary fibrous tumors in the central nervous system: a report of two cases. Kaohsiung J Med Sci 21(4):179–84, 2005.
Bikmaz K, Cosar M, Kurtkaya-Yapicier O, Iplikcioglu AC, Gokduman CA. Recurrent solitary fibrous tumour in the cerebellopontine angle. J Clin Neurosci 12(7):829–32, 2005. doi:10.1016/j.jocn.2004.10.009.
Rodriguez F, Scheithauer B, Ockner D, Giannini C. Solitary fibrous tumor of the cerebellopontine angle with salivary gland heterotopia: a unique presentation. Am J Surg Pathol 28(1):139–42, 2004. doi:10.1097/00000478-200401000-00017.
Pérez-Núñez A, Rivas J, Ricoy J, Miranda P, Arrese I, Lobato R, et al. Solitary fibrous tumor of the tentorium cerebelli. Case report. J Neurosurg Sci 48(2):59–62, 2004.
Lo C, Chen C, Lin C, Chin S, Juan C, Hsueh C. Parasellar solitary fibrous tumor of meninges: magnetic resonance imaging features with pathologic correlation. J Neuroimaging 14(3):281–4, 2004. doi:10.1177/1051228403262708.
Kim KA, Gonzalez I, McComb JG, Giannotta SL. Unusual presentations of cerebral solitary fibrous tumors: report of four cases. Neurosurgery 54(4):1004–9, 2004. doi:10.1227/01.NEU.0000115675.74366.87; discussion 9.
Tihan T, Viglione M, Rosenblum MK, Olivi A, Burger PC. Solitary fibrous tumors in the central nervous system. A clinicopathologic review of 18 cases and comparison to meningeal hemangiopericytomas. Arch Pathol Lab Med 127(4):432–9, 2003.
Sawauchi S, Arakawa H, Taya K, Terao T, Nakazaki H, Numoto R, et al. Solitary fibrous tumor of the fourth ventricle: case report. No Shinkei Geka 31(5):551–5, 2003.
Cassarino D, Auerbach A, Rushing E. Widely invasive solitary fibrous tumor of the sphenoid sinus, cavernous sinus, and pituitary fossa. Ann Diagn Pathol 7(3):169–73, 2003. doi:10.1016/S1092-9134(03)00016-9.
Johnson MD, Powell SZ, Boyer PJ, Weil RJ, Moots PL. Dural lesions mimicking meningiomas. Hum Pathol 33(12):1211–26, 2002. doi:10.1053/hupa.2002.129200.
Castilla E, Prayson R, Stevens G, Barnett G. Brain-invasive solitary fibrous tumor of the meninges: report of a case. Int J Surg Pathol 10(3):217–21, 2002. doi:10.1177/106689690201000311.
Barron J, Lownie S, Lee D, Hammond R. June 2001: 61 year old woman with confusion and obtundation. Brain Pathol 11(4):485–6, 2001.
Shimizu S, Oka H, Kawano N, Utsuki S, Suzuki S, Iwabuchi K, et al. Solitary fibrous tumor arising from the falx cerebri—case report. Neurol Med Chir (Tokyo) 40(12):650–4, 2000. doi:10.2176/nmc.40.650.
Rodríguez L, López J, Marin A, Cardozo D, Molina O, Cardozo J. Solitary fibrous tumor of the meninges. Clin Neuropathol 19(1):45–8, 2000.
Nawashiro H. Intracranial solitary fibrous tumor of the meninges. Hum Pathol 31(12):1536, 2000. doi:10.1053/hupa.2000.21061.
Nikas D, De Girolami U, Folkerth R, Bello L, Zamani A, Black P. Parasagittal solitary fibrous tumor of the meninges. Case report and review of the literature. Acta Neurochir (Wien). 141(3):307–13, 1999. doi:10.1007/s007010050302.
Brunori A, Cerasoli S, Donati R, Giangaspero F, Chiappetta F. Solitary fibrous tumor of the meninges: two new cases and review of the literature. Surg Neurol 51(6):636–40, 1999. doi:10.1016/S0090-3019(98)00115-3.
Slavik T, Bentley R, Gray L, Fuchs H, McLendon R. Solitary fibrous tumor of the meninges occurring after irradiation of a mixed germ cell tumor of the pineal gland. Clin Neuropathol 17(1):55–60, 1998.
Freda P, Wardlaw S, Post K. Unusual causes of sellar/parasellar masses in a large transsphenoidal surgical series. J Clin Endocrinol Metab 81(10):3455–9, 1996.
Glezer A, Paraiba D, Bronstein M. Rare sellar lesions. Endocrinol Metab Clin North Am 37(1):195–211, 2008. doi:10.1016/j.ecl.2007.10.003.
Rennert J, Doerfler A. Imaging of sellar and parasellar lesions. Clin Neurol Neurosurg 109(2):111–24, 2007. doi:10.1016/j.clineuro.2006.11.001.
Asa SL, Kovacs K, Horvath E, Ezrin C, Weiss MH. Sellar glomangioma. Ultrastruct Pathol 7(1):49–54, 1984. doi:10.3109/01913128409141853.
Asa SL. Tumors of the Pituitary Gland, Atlas of Tumor Pathology, Third series, fascicle 22. Washington DC: Armed Forces Institute of Pathology, 1998.
Acknowledgements
We would like to express our gratitude to all the medical personnel that contributed to the patient care, especially Drs. Maritza Cantarelli and Jose Henrique Muller.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Furlanetto, T.W., Pinheiro, C.F.P., Oppitz, P.P. et al. Solitary Fibrous Tumor of the Sella Mimicking Pituitary Adenoma: An Uncommon Tumor in a Rare Location—A Case Report. Endocr Pathol 20, 56–61 (2009). https://doi.org/10.1007/s12022-009-9063-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12022-009-9063-5